OSAKA -- Activist investor Oasis Management has requested that Kobayashi Pharmaceutical hold an extraordinary shareholders meeting in response to the scandal surrounding a red yeast supplement linked to dozens of deaths, the Japanese drugmaker said Monday.
Pharmaceuticals
Oasis seeks shareholder meeting at Kobayashi Pharma amid yeast scandal
Activist investor wants independent directors and new investigator at Japanese drugmaker
.jpg?width=780&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto)
Kobayashi Pharmaceutical's red yeast supplement has been linked to dozens of deaths. (Photo by Koji Uema)
Read Next
Latest on Pharmaceuticals
